checkedPsychopharmacology and Psychiatry Updates2026-11-18last verified 2026-11-18

does lumateperone cost $18 a month like generic aripiprazole and quetiapine?

verdict: false
the primary source contradicts it
“generic aeropipousol costs $16 a month. The utipine immediate release costs $9 a month, whereas brex pipousol, about $1500 a month and Lumetepiron $18 a month.”

a guest, research editor at the Psychopharmacology Institute and medical director of depressioneducation.org said on Psychopharmacology and Psychiatry Updates, 2026-11-18, at 06:44. hear it in context → the speaker cited: GoodRx website data.

the episode: Which Adjunctive Antipsychotic Is Best for Major Depression? (at 06:44). we link the show's own page; we do not re-host audio.

first, the part that holds

Three of the four numbers fit the federal record. Brexpiprazole really does run about $1,500 a month: pharmacies pay about $49.50 a tablet, roughly $1,485 for 30. Generic aripiprazole and immediate-release quetiapine really do cost a few dollars a month at the pharmacy's purchase price, so retail cash prices of $16 and $9 are believable.

what we found when we went and looked

We could not open GoodRx, the source the speaker named, because it is not on our list of primary records. Instead we used CMS's national average drug acquisition cost (NADAC) data, which reports what US retail pharmacies pay per tablet. In the November 2026 file, 30 tablets of brexpiprazole cost pharmacies about $1,485, which matches the $1,500 figure. Generic aripiprazole came to about $3.50–$5.50 for 30 tablets and immediate-release quetiapine to about $0.60–$4.80, both low enough that $16 and $9 cash prices are plausible. Lumateperone breaks the pattern: pharmacies pay about $57 per capsule, roughly $1,716 for 30, and the file lists no generic version, so "$18 a month" is off by nearly a hundredfold. The $18 figure would fit generic lurasidone, which costs pharmacies about $4–$15 a month, but we cannot confirm that this is what was meant.

assertion by assertion

assertionverdictwhat the record says
generic aripiprazole costs about $16 a month on goodrxunverifiableWe cannot check the GoodRx price itself. The CMS acquisition cost, effective 2026-10-21, is $0.11651–$0.18278 per tablet for 2–30 mg, so 30 tablets cost a pharmacy about $3.50 (5–10 mg) to $5.48 (30 mg). A $16 retail cash price, which adds dispensing fees and markup, is consistent with that. [1][6]
quetiapine immediate release costs about $9 a month on goodrxunverifiableWe cannot check the GoodRx price itself. The CMS acquisition cost for generic immediate-release tablets is $0.02090 (25 mg) to $0.16013 (400 mg) per tablet, so 30 tablets cost a pharmacy about $0.63–$4.80 at once-daily dosing. A $9 cash price is consistent with that. Twice-daily regimens would double the tablet count, and the 150 mg strength is a pricing outlier at $1.25518 per tablet. [2][6]
brexpiprazole costs about $1,500 a monthconfirmedEvery strength from 0.25 to 4 mg has a CMS acquisition cost of $49.47–$49.57 per tablet (as of 2026-11-18), so 30 once-daily tablets cost about $1,484–$1,487. The file lists only the brand-name product. Because this is what the pharmacy pays, a GoodRx cash price would sit at or above it. [3][6]
lumateperone costs about $18 a monthfalseThe CMS acquisition cost is $57.20–$57.24 per capsule for 10.5, 21 and 42 mg (as of 2026-11-18), so 30 once-daily capsules cost about $1,716. A search of the whole 2026 file for a generic version returned zero rows; only the brand-name product appears. No pharmacy can buy a month's supply anywhere near $18. [4]
the $18 figure may belong to generic lurasidone, a similar-sounding drugunverifiableGeneric lurasidone has a CMS acquisition cost of $0.14539 (20 mg) to $0.49577 (120 mg) per tablet, or about $4.36–$14.87 for 30 tablets, which would fit an $18 cash price. We have no transcript correction or GoodRx record to show which drug the speaker meant. [5]

both directions

for the speaker: The overall point holds up in the federal data: older generic antipsychotics cost pharmacies pennies per tablet, while the newer brand-only drugs cost about $50 a tablet or more. The brexpiprazole figure ($1,500 a month) matches what pharmacies pay almost exactly. The aripiprazole and quetiapine figures are a few dollars above pharmacy purchase cost, which is what a cash coupon price usually looks like.

against: The lumateperone clause is wrong by about a hundredfold. Pharmacies pay about $57 per capsule and there is no generic in the CMS file, so a month costs pharmacies about $1,716, not $18. That makes lumateperone even more expensive than brexpiprazole, the opposite of what the quote implies. Anyone using the quote to compare costs would conclude lumateperone is as cheap as the generics, which is backwards.

what this cannot say

We could not read GoodRx, so we have no direct check on any of the four cash prices. NADAC measures what pharmacies pay to buy a drug, not what a patient pays at the counter. It leaves out dispensing fees, pharmacy markup, insurance copays and manufacturer savings programs, and its generic rates have used a three-month moving average since December 2024. GoodRx prices also vary by pharmacy, zip code and date. Our monthly figures assume one tablet or capsule a day for 30 days, and actual doses vary, especially for quetiapine. We cannot tell whether "lumateperone" was a slip of the tongue, a transcription error or a data error.

the medication pages behind this check

sources, each one fetched and read

  1. Centers for Medicare & Medicaid Services, NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov dataset fbb83258-11c7-47f5-8b18-5f8e79f7e704, aripiprazole rows, as of 2026-11-04 What we read there: Generic aripiprazole tablets (classification G), effective 2026-10-21: 2 mg $0.12058, 5 mg $0.11651, 10 mg $0.11861, 15 mg $0.13378, 20 mg $0.18177, 30 mg $0.18278 per tablet. Fetched 2026-11-18 (HTTP 200). https://data.medicaid.gov/api/1/datastore/query/fbb83258-11c7-47f5-8b18-5f8e79f7e704/0?conditions[0][property]=as_of_date&conditions[0][value]=2026-11-01&conditions[0][operator]=>&conditions[1][property]=ndc_description&conditions[1][value]=%25PIPRAZOLE%25&conditions[1][operator]=like&limit=200
  2. Centers for Medicare & Medicaid Services, NADAC 2026, data.medicaid.gov, quetiapine rows, as of 2026-11-04/11 What we read there: Generic quetiapine fumarate immediate-release tablets, effective 2026-10-21: 25 mg $0.02090, 50 mg $0.02924, 100 mg $0.04831, 200 mg $0.09369, 300 mg $0.12778, 400 mg $0.16013 per tablet; 150 mg $1.25518 per tablet. Fetched 2026-11-18 (HTTP 200). https://data.medicaid.gov/api/1/datastore/query/fbb83258-11c7-47f5-8b18-5f8e79f7e704/0?conditions[0][property]=as_of_date&conditions[0][value]=2026-11-01&conditions[0][operator]=>&conditions[1][property]=ndc_description&conditions[1][value]=QUETIAPINE%25&conditions[1][operator]=like&limit=200
  3. Centers for Medicare & Medicaid Services, NADAC 2026, data.medicaid.gov, brexpiprazole (brand-only) rows, as of 2026-11-04/11/18 What we read there: Brexpiprazole tablets 0.25–4 mg (classification B), as of 2026-11-18: $49.46682–$49.56601 per tablet; a search of the 2026 file for a generic brexpiprazole description returned 0 rows. Fetched 2026-11-18 (HTTP 200). https://data.medicaid.gov/api/1/datastore/query/fbb83258-11c7-47f5-8b18-5f8e79f7e704/0?conditions[0][property]=as_of_date&conditions[0][value]=2026-11-01&conditions[0][operator]=>&conditions[1][property]=ndc_description&conditions[1][value]=REXULTI%25&conditions[1][operator]=like&limit=100
  4. Centers for Medicare & Medicaid Services, NADAC 2026, data.medicaid.gov, lumateperone (brand-only) rows, as of 2026-11-04/11/18 What we read there: Lumateperone capsules (classification B), effective 2026-11-18: 10.5 mg $57.23440, 21 mg $57.19980, 42 mg $57.23406 per capsule; a search of the 2026 file for a generic lumateperone description returned count 0. Fetched 2026-11-18 (HTTP 200). https://data.medicaid.gov/api/1/datastore/query/fbb83258-11c7-47f5-8b18-5f8e79f7e704/0?conditions[0][property]=as_of_date&conditions[0][value]=2026-11-01&conditions[0][operator]=>&conditions[1][property]=ndc_description&conditions[1][value]=CAPLYTA%25&conditions[1][operator]=like&limit=100
  5. Centers for Medicare & Medicaid Services, NADAC 2026, data.medicaid.gov, lurasidone rows, as of 2026-11-04/11 What we read there: Generic lurasidone tablets (classification G), effective 2026-10-21: 20 mg $0.14539, 40 mg $0.21230, 60 mg $0.29869, 80 mg $0.32501, 120 mg $0.49577 per tablet. Fetched 2026-11-18 (HTTP 200). https://data.medicaid.gov/api/1/datastore/query/fbb83258-11c7-47f5-8b18-5f8e79f7e704/0?conditions[0][property]=as_of_date&conditions[0][value]=2026-11-01&conditions[0][operator]=>&conditions[1][property]=ndc_description&conditions[1][value]=LURASIDONE%25&conditions[1][operator]=like&limit=100
  6. Centers for Medicare & Medicaid Services, Pharmacy Pricing (NADAC), medicaid.gov What we read there: "We update the National Average Drug Acquisition Cost (NADAC) data and comparison data weekly"; starting December 2024, generic drug rates use a temporary three-month moving average until further notice. Fetched 2026-11-18 (HTTP 200). https://www.medicaid.gov/medicaid/prescription-drugs/pharmacy-pricing

speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam